Germline epimutation: A basis for epigenetic disease in humans

Annals of the New York Academy of Sciences

Volumn 1054, Issue , 2005, Pages 68-77

  Martin, David I K ^a,b,d   Ward, Robyn ^b,c   Suter, Catherine M ^a  

^a VICTOR CHANG CARDIAC RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c ST VINCENT S HOSPITAL   (Australia)

^d CHILDREN S HOSPITAL OAKLAND RESEARCH INSTITUTE   (United States)

Author keywords

DNA mismatch; Epimutation; MLH1; Thalassemia

Indexed keywords

PROTEIN MLH1;

ALLELE; CLONE; COLORECTAL CANCER; CONFERENCE PAPER; DNA MODIFICATION; DNA TRANSCRIPTION; EPIGENETICS; EUKARYOTE; GENE INACTIVATION; GENE MUTATION; GENE SILENCING; GERM LINE; HETEROZYGOSITY LOSS; HUMAN; INHERITANCE; MOSAICISM; PHENOTYPE; STOCHASTIC MODEL; THALASSEMIA;

EUKARYOTA;

EID: 29744470898     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1345.009     Document Type: Conference Paper

References (32)

1. WOLFFE, A.P. & M.A. MATZKE. 1999. Epigenetics: regulation through repression. Science 286: 481-486.
2. FISCHLE, W., Y. WANG & C.D. ALLIS. 2003. Binary switches and modification cassettes in histone biology and beyond. Nature 425: 475-479.
3. JIANG, Y.H., J. BRESSLER & A.L. BEAUDET. 2004. Epigenetics and human disease. Annu. Rev. Genomics Hum. Genet. 5: 479-510.
4. JENUWEIN, T. & C.D. ALLIS. 2001. Translating the histone code. Science 293: 1074-1080.
5. BIRD, A. 2002. DNA methylation patterns and epigenetic memory. Genes Dev. 16: 6-21.
6. MOAZED, D. 2001. Common themes in mechanisms of gene silencing. Mol. Cell 8: 489-498.
7. MATZKE, M.A. & J.A. BIRCHLER. 2005. RNAi-mediated pathways in the nucleus. Nat. Rev. Genet. 6: 24-35.
8. ZHIMULEV, I.F. & E.S. BELYAEVA. 2003. Intercalary heterochromatin and genetic silencing. Bioessays 25: 1040-1051.
9. CHANDLER, V.L. & M. STAM. 2004. Chromatin conversations: mechanisms and implications of paramutation. Nat. Rev. Genet. 5: 532-544.
10. JONES, P.A. & S.B. BAYLIN. 2002. The fundamental role of epigenetic events in cancer. Nat. Rev. Genet. 3: 415-428.
11. TUFARELLI, C., J.A. STANLEY, D. GARRICK, et al. 2003. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat. Genet. 34: 157-165.
12. REIK, W., W. DEAN & J. WALTER. 2001. Epigenetic reprogramming in mammalian development. Science 293: 1089-1093.
13. LANE, N., W. DEAN, S. ERHARDT, et al. 2003. Resistance of IAPs to methylation reprogramming may provide a mechanism for epigenetic inheritance in the mouse. Genesis 35: 88-93.
14. MORGAN, H.D., H.G. SUTHERLAND, D.I. MARTIN & E. WHITELAW. 1999. Epigenetic inheritance at the agouti locus in the mouse. Nat. Genet. 23: 314-318.
15. RAKYAN, V. & E. WHITELAW. 2003. Transgenerational epigenetic inheritance. Curr. Biol. 13: R6.
16. CUBAS, P., C. VINCENT & E. COEN. 1999. An epigenetic mutation responsible for natural variation in floral symmetry. Nature 401: 157-161.
17. GARBER, J.E. & K. OFFIT. 2005. Hereditary cancer predisposition syndromes. J. Clin. Oncol. 23: 276-292.
18. BAYLIN, S.B., M. ESTELLER, M.R. ROUNTREE, et al. 2001. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer. Hum. Mol. Genet. 10: 687-692.
19. SUTER, C.M., D.I. MARTIN & R.L. WARD. 2004. Germline epimutation of MLH1 in individuals with multiple cancers. Nat. Genet. 36: 497-501.
20. XIONG, Z. & P.W. LAIRD. 1997. COBRA: a sensitive and quantitative DNA methylation assay. Nucleic Acids Res. 25: 2532-2534.
21. HERMAN, J.G., J.R. GRAFF, S. MYOHANEN, et al. 1996. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. USA 93: 9821-9826.
22. CHUNG, D.C. & A.K. RUSTGI. 2003. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann. Intern. Med. 138: 560-570.
23. CLARK, S.J., J. HARRISON, C.L. PAUL & M. FROMMER 1994. High sensitivity mapping of methylated cytosines. Nucleic Acids Res. 22: 2990-2997.
24. STOGER, R., T.M. KAJIMURA, W.T. BROWN & C.D. LAIRD. 1997. Epigenetic variation illustrated by DNA methylation patterns of the fragile-X gene FMR1. Hum. Mol. Genet. 6: 1791-1801.
25. GAZZOLI, I., M. LODA, J. GARBER, et al. 2002. A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor. Cancer Res. 62: 3925-3928.
26. MIYAKURA, Y., K. SUGANO, T. AKASU, et al. 2004. Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability. Clin. Gastroenterol. Hepatol. 2: 147-156.
27. DENG, G., A. CHEN, J. HONG, et al. 1999. Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression. Cancer Res. 59: 2029-2033.
28. MURRELL, A., S. HEESON, W.N. COOPER, et al. 2004. An association between variants in the IGF2 gene and Beckwith-Wiedemann syndrome: interaction between genotype and epigenotype. Hum. Mol. Genet. 13: 247-255.
29. BESTOR, T.H. 2003. Unanswered questions about the role of promoter methylation in carcinogenesis. Ann. N.Y. Acad. Sci. 983: 22-27.
30. WEATHERALL, D.J. & J.B. CLEGG. 2001. The Thalassaemia Syndromes. Blackwell Sciences. Oxford.
31. VAN OVERVELD, P.G., R.J. LEMMERS, L.A. SANDKUIJL, et al. 2003. Hypomethylation of D4Z4 in 4q-linked and non-4q-linked facioscapulohumeral muscular dystrophy. Nat. Genet. 35: 315-317.
32. WEATHERALL, D.J. 2001. Phenotype-genotype relationships in monogenic disease: lessons from the thalassaemias. Nat. Rev. Genet. 2: 245-255.